99 related articles for article (PubMed ID: 18086280)
1. Fungal and mycobacterial infections after Campath (alemtuzumab) induction for renal transplantation.
Walsh R; Ortiz J; Foster P; Palma-Vargas J; Rosenblatt S; Wright F
Transpl Infect Dis; 2008 Jul; 10(4):236-9. PubMed ID: 18086280
[TBL] [Abstract][Full Text] [Related]
2. Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody.
Peleg AY; Husain S; Kwak EJ; Silveira FP; Ndirangu M; Tran J; Shutt KA; Shapiro R; Thai N; Abu-Elmagd K; McCurry KR; Marcos A; Paterson DL
Clin Infect Dis; 2007 Jan; 44(2):204-12. PubMed ID: 17173218
[TBL] [Abstract][Full Text] [Related]
3. Fungal infections in transplant recipients receiving alemtuzumab.
Nath DS; Kandaswamy R; Gruessner R; Sutherland DE; Dunn DL; Humar A
Transplant Proc; 2005 Mar; 37(2):934-6. PubMed ID: 15848579
[TBL] [Abstract][Full Text] [Related]
4. Campath-1H (alemtuzumab) as an induction agent for the prevention of graft rejection and preservation of renal function in kidney transplant patients: Philippine 3-year follow-up.
Muñoz AS; Cabanayan-Casasola CB; Danguilan RA; Padua FB; Ona ET
Transplant Proc; 2008 Sep; 40(7):2230-3. PubMed ID: 18790200
[TBL] [Abstract][Full Text] [Related]
5. Alemtuzumab induction in deceased donor kidney transplantation.
Shin M; Song SH; Kim JM; Kwon CH; Joh JW; Lee SK; Kim SJ
Transplant Proc; 2011; 43(6):2365-78. PubMed ID: 21839271
[TBL] [Abstract][Full Text] [Related]
6. Infections after the use of alemtuzumab in solid organ transplant recipients: a comparative study.
Safdar N; Smith J; Knasinski V; Sherkow C; Herrforth C; Knechtle S; Andes D
Diagn Microbiol Infect Dis; 2010 Jan; 66(1):7-15. PubMed ID: 19963164
[TBL] [Abstract][Full Text] [Related]
7. Experience with Alemtuzumab (Campath-1H) as induction agent in renal transplantation followed by steroid-free immunosuppression.
Baez Y; Giron F; Niño-Murcia A; Rodríguez J; Salcedo S
Transplant Proc; 2008 Apr; 40(3):697-9. PubMed ID: 18454990
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis due to Mycobacterium bovis after alemtuzumab administration.
Abad S; Gyan E; Moachon L; Bouscary D; Sicard D; Dreyfus F; Blanche P
Clin Infect Dis; 2003 Jul; 37(2):e27-8. PubMed ID: 12856232
[TBL] [Abstract][Full Text] [Related]
9. Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period.
Zanfi C; Lauro A; Cescon M; Dazzi A; Ercolani G; Grazi GL; Zanello M; Vivarelli M; Del Gaudio M; Ravaioli M; Cucchetti A; Vetrone G; Tuci F; Di Gioia P; Lazzarotto T; D'Errico A; Bagni A; Faenza S; Siniscalchi A; Pironi L; Pinna AD
Transplant Proc; 2010; 42(1):35-8. PubMed ID: 20172276
[TBL] [Abstract][Full Text] [Related]
10. Alemtuzumab versus interleukin-2 receptor antibodies induction in living donor kidney transplantation.
Sampaio MS; Kadiyala A; Gill J; Bunnapradist S
Transplantation; 2009 Oct; 88(7):904-10. PubMed ID: 19935462
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
Farney AC; Doares W; Rogers J; Singh R; Hartmann E; Hart L; Ashcraft E; Reeves-Daniels A; Gautreaux M; Iskandar SS; Moore P; Adams PL; Stratta RJ
Transplantation; 2009 Sep; 88(6):810-9. PubMed ID: 19920781
[TBL] [Abstract][Full Text] [Related]
12. Alemtuzumab induction and triple maintenance immunotherapy in kidney transplantation from donors after cardiac death.
Schadde E; D'Alessandro AM; Knechtle SJ; Odorico J; Becker Y; Pirsch J; Sollinger H; Fernandez LA
Transpl Int; 2008 Jul; 21(7):625-36. PubMed ID: 18397178
[TBL] [Abstract][Full Text] [Related]
13. Campath induction for kidney transplantation: report of 297 cases.
Ortiz J; Palma-Vargas J; Wright F; Bingaman A; Agha I; Rosenblatt S; Foster P
Transplantation; 2008 Jun; 85(11):1550-6. PubMed ID: 18551058
[TBL] [Abstract][Full Text] [Related]
14. Use of alemtuzumab (Campath-1H) as induction therapy in pediatric kidney transplantation.
Ona ET; Danguilan RA; Africa J; Cabanayan-Casasola CB; Antonio ZL; Gutierrez-Marbella MA; dela Cruz R; Bumanglag N; Espedilla ME
Transplant Proc; 2008 Sep; 40(7):2226-9. PubMed ID: 18790199
[TBL] [Abstract][Full Text] [Related]
15. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
Lü TM; Yang SL; Wu WZ; Tan JM
Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554
[TBL] [Abstract][Full Text] [Related]
16. Tuberculous hepatitis in renal transplant recipients following alemtuzumab induction therapy.
Bosch W; Poowanawittayakom N; Chaikriangkrai K; Mendez J; Hellinger WC; Gonwa TA; Krishna M; Pungpapong S
Transpl Infect Dis; 2013 Feb; 15(1):E33-9. PubMed ID: 23278987
[TBL] [Abstract][Full Text] [Related]
17. Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation.
Pascual J; Pirsch JD; Odorico JS; Torrealba JR; Djamali A; Becker YT; Voss B; Leverson GE; Knechtle SJ; Sollinger HW; Samaniego-Picota MD
Transplantation; 2009 Jan; 87(1):125-32. PubMed ID: 19136902
[TBL] [Abstract][Full Text] [Related]
18. Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation.
Pascual J; Mezrich JD; Djamali A; Leverson G; Chin LT; Torrealba J; Bloom D; Voss B; Becker BN; Knechtle SJ; Sollinger HW; Pirsch JD; Samaniego MD
Transplantation; 2007 Jun; 83(11):1429-34. PubMed ID: 17565315
[TBL] [Abstract][Full Text] [Related]
19. Alemtuzumab induction in kidney transplantation: clinical results and impact on T-regulatory cells.
Morales J; Bono MR; Fierro A; Iñiguez R; Zehnder C; Rosemblatt M; Calabran L; Herzog C; Benavente D; Aguiló J; Pefaur J; Alba A; Ferrario M; Simon W; Contreras L; Buckel E
Transplant Proc; 2008 Nov; 40(9):3223-8. PubMed ID: 19010240
[TBL] [Abstract][Full Text] [Related]
20. Herpes zoster infection after liver transplantation in patients receiving induction therapy with alemtuzumab.
Alcaide ML; Abbo L; Pano JR; Gaynor JJ; Tryphonopoulos P; Weppler D; Moon JI; Tzakis AG; Morris MI
Clin Transplant; 2008; 22(4):502-7. PubMed ID: 18627401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
